CN102236015A - 一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 - Google Patents
一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 Download PDFInfo
- Publication number
- CN102236015A CN102236015A CN2011100909186A CN201110090918A CN102236015A CN 102236015 A CN102236015 A CN 102236015A CN 2011100909186 A CN2011100909186 A CN 2011100909186A CN 201110090918 A CN201110090918 A CN 201110090918A CN 102236015 A CN102236015 A CN 102236015A
- Authority
- CN
- China
- Prior art keywords
- antibody
- counterdie
- kit
- specific antibodies
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 29
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 28
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 28
- 230000002860 competitive effect Effects 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 208000008589 Obesity Diseases 0.000 title abstract description 6
- 235000020824 obesity Nutrition 0.000 title abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 25
- 238000001514 detection method Methods 0.000 claims abstract description 20
- 239000000376 reactant Substances 0.000 claims abstract description 8
- 239000000427 antigen Substances 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 4
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 229960002685 biotin Drugs 0.000 claims description 10
- 235000020958 biotin Nutrition 0.000 claims description 10
- 239000011616 biotin Substances 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 9
- 239000000020 Nitrocellulose Substances 0.000 claims description 9
- 229920001220 nitrocellulos Polymers 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 9
- 108010090804 Streptavidin Proteins 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 6
- 229940098773 bovine serum albumin Drugs 0.000 claims description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
- 238000002965 ELISA Methods 0.000 claims description 5
- 239000007983 Tris buffer Substances 0.000 claims description 5
- 239000003112 inhibitor Substances 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 239000004677 Nylon Substances 0.000 claims description 4
- 239000002033 PVDF binder Substances 0.000 claims description 4
- 229920001778 nylon Polymers 0.000 claims description 4
- -1 phylaxin Proteins 0.000 claims description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- 102000011690 Adiponectin Human genes 0.000 claims description 3
- 108010076365 Adiponectin Proteins 0.000 claims description 3
- 108010064733 Angiotensins Proteins 0.000 claims description 3
- 102000015427 Angiotensins Human genes 0.000 claims description 3
- 102100020948 Growth hormone receptor Human genes 0.000 claims description 3
- 102400000064 Neuropeptide Y Human genes 0.000 claims description 3
- 101800003845 Neuropeptide Y Proteins 0.000 claims description 3
- 102000012288 Phosphopyruvate Hydratase Human genes 0.000 claims description 3
- 108010022181 Phosphopyruvate Hydratase Proteins 0.000 claims description 3
- 108010068542 Somatotropin Receptors Proteins 0.000 claims description 3
- 210000000612 antigen-presenting cell Anatomy 0.000 claims description 3
- 210000004204 blood vessel Anatomy 0.000 claims description 3
- 150000002596 lactones Chemical class 0.000 claims description 3
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000002103 transcriptional effect Effects 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 12
- 230000004907 flux Effects 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 2
- 210000002469 basement membrane Anatomy 0.000 abstract 4
- 230000007547 defect Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 description 46
- 239000000243 solution Substances 0.000 description 13
- 238000004140 cleaning Methods 0.000 description 11
- 238000002474 experimental method Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 8
- 235000018102 proteins Nutrition 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000013641 positive control Substances 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000003636 conditioned culture medium Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002985 plastic film Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 102000016267 Leptin Human genes 0.000 description 3
- 108010092277 Leptin Proteins 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000002950 deficient Effects 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940039781 leptin Drugs 0.000 description 3
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108091058545 Secretory proteins Proteins 0.000 description 1
- 102000040739 Secretory proteins Human genes 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000012496 blank sample Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000024203 complement activation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110090918.6A CN102236015B (zh) | 2011-04-12 | 2011-04-12 | 一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110090918.6A CN102236015B (zh) | 2011-04-12 | 2011-04-12 | 一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102236015A true CN102236015A (zh) | 2011-11-09 |
CN102236015B CN102236015B (zh) | 2014-11-05 |
Family
ID=44886868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110090918.6A Active CN102236015B (zh) | 2011-04-12 | 2011-04-12 | 一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102236015B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559694A (zh) * | 2012-02-23 | 2012-07-11 | 中国医学科学院医学生物学研究所 | 一种猕猴抵抗素基因cDNA全长序列的克隆方法 |
CN102721819A (zh) * | 2012-06-28 | 2012-10-10 | 广州瑞博奥生物科技有限公司 | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN102721818A (zh) * | 2012-06-28 | 2012-10-10 | 广州瑞博奥生物科技有限公司 | 一种内脂素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN102749455A (zh) * | 2012-06-26 | 2012-10-24 | 博奥赛斯(天津)生物科技有限公司 | 血管紧张素ⅱ化学发光免疫定量检测试剂盒及其制备方法 |
CN104569418A (zh) * | 2013-10-12 | 2015-04-29 | 广州瑞博奥生物科技有限公司 | 一种用于生物标记物筛选的抗体芯片试剂盒 |
CN104833809A (zh) * | 2015-05-05 | 2015-08-12 | 南京闻智生物科技有限公司 | 一种用于测定抵抗素的胶乳增强免疫比浊试剂盒及其制备方法和检测方法 |
CN104880564A (zh) * | 2015-04-30 | 2015-09-02 | 南京格耀生物科技有限公司 | 一种检测抵抗素的试剂盒及其制备方法和检测方法 |
CN108120838A (zh) * | 2017-12-22 | 2018-06-05 | 苏州博源医疗科技有限公司 | 用于血管紧张素ⅱ检测的二肽衍生物及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005094200A2 (en) * | 2003-06-20 | 2005-10-13 | University Of Florida | Biomarkers for differentiating between type 2 and type 2 diabetes |
CN101833001A (zh) * | 2010-04-21 | 2010-09-15 | 黄若磐 | 一种检测炎症因子的蛋白质芯片试剂盒及其制备方法 |
CN101858909A (zh) * | 2010-05-28 | 2010-10-13 | 黄若磐 | 检测磷酸化表皮生长因子受体的试剂盒及其制备方法 |
-
2011
- 2011-04-12 CN CN201110090918.6A patent/CN102236015B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005094200A2 (en) * | 2003-06-20 | 2005-10-13 | University Of Florida | Biomarkers for differentiating between type 2 and type 2 diabetes |
CN101833001A (zh) * | 2010-04-21 | 2010-09-15 | 黄若磐 | 一种检测炎症因子的蛋白质芯片试剂盒及其制备方法 |
CN101858909A (zh) * | 2010-05-28 | 2010-10-13 | 黄若磐 | 检测磷酸化表皮生长因子受体的试剂盒及其制备方法 |
Non-Patent Citations (10)
Title |
---|
ERMAN A ET AL.: "Human growth hormone receptor (GHR) expression in obesity: II.Regulation of the human GHR gene by obesity-related factors", 《INR J OBES(LOND)》 * |
TUOMO RANKINEN ET AL.: "The Human Obesity Gene Map:The 2005 Update", 《OBESITY》 * |
吕建波 等: "血清瘦素、血管紧张素-2、肿瘤坏死因子与肥胖型高血压的相关性研究", 《中国老年学杂志》 * |
张丽红 等: "神经肽Y与肥胖的关系及其在运动减肥中的应用", 《成都体育学院学报》 * |
潘优津 等: "肥胖及糖调节受损患者血视黄醇结合蛋白4的变化及临床意义", 《中国糖尿病杂志》 * |
胡晓武 等: "高血脂状态对血清VAP_1表达水平的影响及意义", 《中国误诊学杂志》 * |
胡艳: "炎症与代谢综合征", 《国外医学内科学分册》 * |
范静静 等: "内脂素与肥胖和2型糖尿病的相关性研究进展", 《中华全科医学》 * |
邹赢锌 等: "可卡因-苯丙胺调节转录肽与肥胖关系研究进展", 《癌变.畸变.突变》 * |
高小亚 等: "单纯性肥胖患者血清瘦素、抵抗素和脂联素水平的研究", 《医学研究生学报》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102559694A (zh) * | 2012-02-23 | 2012-07-11 | 中国医学科学院医学生物学研究所 | 一种猕猴抵抗素基因cDNA全长序列的克隆方法 |
CN102749455A (zh) * | 2012-06-26 | 2012-10-24 | 博奥赛斯(天津)生物科技有限公司 | 血管紧张素ⅱ化学发光免疫定量检测试剂盒及其制备方法 |
CN102749455B (zh) * | 2012-06-26 | 2014-12-10 | 博奥赛斯(天津)生物科技有限公司 | 血管紧张素ⅱ化学发光免疫定量检测试剂盒及其制备方法 |
CN102721819A (zh) * | 2012-06-28 | 2012-10-10 | 广州瑞博奥生物科技有限公司 | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN102721818A (zh) * | 2012-06-28 | 2012-10-10 | 广州瑞博奥生物科技有限公司 | 一种内脂素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN102721819B (zh) * | 2012-06-28 | 2014-08-13 | 广州瑞博奥生物科技有限公司 | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 |
CN104569418A (zh) * | 2013-10-12 | 2015-04-29 | 广州瑞博奥生物科技有限公司 | 一种用于生物标记物筛选的抗体芯片试剂盒 |
CN104569418B (zh) * | 2013-10-12 | 2016-06-29 | 广州瑞博奥生物科技有限公司 | 一种用于生物标记物筛选的抗体芯片试剂盒 |
CN104880564A (zh) * | 2015-04-30 | 2015-09-02 | 南京格耀生物科技有限公司 | 一种检测抵抗素的试剂盒及其制备方法和检测方法 |
CN104833809A (zh) * | 2015-05-05 | 2015-08-12 | 南京闻智生物科技有限公司 | 一种用于测定抵抗素的胶乳增强免疫比浊试剂盒及其制备方法和检测方法 |
CN108120838A (zh) * | 2017-12-22 | 2018-06-05 | 苏州博源医疗科技有限公司 | 用于血管紧张素ⅱ检测的二肽衍生物及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN102236015B (zh) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102236015B (zh) | 一种检测肥胖因子的竞争抑制性酶联免疫芯片试剂盒及其制备方法 | |
Choi et al. | A rapid, simple measurement of human albumin in whole blood using a fluorescence immunoassay (I) | |
CN102323422B (zh) | 半定量同时检测cTnI和Myo的免疫层析试纸条及其制备 | |
DK160108C (da) | Fremgangsmåde og udstyr til direkte eller indirekte påvisning af reaktion mellem et specifikt bindingsmiddel og den tilsvarende acceptorsubstans | |
CN106153927A (zh) | 一种快速定量同时检测cTnI、CKMB、Myo的时间分辨荧光免疫层析试剂及制备方法 | |
AU592971B2 (en) | Solid phase diffusion assay | |
CN102135498B (zh) | 一种以多捕获特性为特征的半定量胶体金属检测技术及其制备方法和用途 | |
CN108414766A (zh) | 用于定量检测糖尿病自身抗体的试剂盒及其应用 | |
CN104099300A (zh) | 可分泌抗牛免疫球蛋白IgG单克隆抗体的杂交瘤细胞株及其应用 | |
CN112858696B (zh) | 肝素结合蛋白测定试剂盒 | |
CN109001471A (zh) | 游离人绒毛膜促性腺激素β亚单位化学发光检测试剂盒及其制备方法和使用方法 | |
CN113687087A (zh) | 一种甲状旁腺激素快速检测卡及其制备方法 | |
JPS63127160A (ja) | 特異的蛋白質の検出方法 | |
CN103630692B (zh) | 快速检测尿液c肽的胶体金免疫层析试剂盒及其检测方法 | |
CN102943066A (zh) | 一种人载脂蛋白b100单克隆抗体及其化学发光免疫分析测定试剂盒 | |
CN101963618B (zh) | 在抗体微阵列系统中识别异嗜性抗体干扰的方法及应用其检测目标抗原的抗体微阵列芯片 | |
CN116679066A (zh) | 基于荧光免疫层析法定量检测高尔基体糖蛋白73的试剂盒及其应用 | |
Christiansen et al. | A particle-enhanced turbidimetric immunoassay for quantitative determination of orosomucoid in urine: development, validation and reference values | |
CN102721819B (zh) | 一种脂联素的竞争抑制性酶联免疫检测试剂盒及方法 | |
CN209231349U (zh) | 一种量子点免疫层析法膀胱癌检测试剂盒 | |
Townsend | Increased albumin excretion in diabetes. | |
CN104987380A (zh) | 一种检测血浆炎性细胞因子自身抗体的组合物、试剂盒与方法 | |
JPH01165960A (ja) | トランスフェリンの測定方法 | |
Exss et al. | Computer analysis of amino acid chromatograms | |
Nisselbaum et al. | Comparison of Roche RIA, Roche EIA, Hybritech EIA, and Abbott EIA methods for measuring carcinoembryonic antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: GUANGZHOU RAYBIOTECH, INC. Owner name: GUANGZHOU RAYBIOTECH, INC. Free format text: FORMER OWNER: HUANG RUOPAN Effective date: 20111115 |
|
C10 | Entry into substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Ruopan Inventor after: Jiang Weidong Inventor before: Huang Ruopan |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; TO: 510663 GUANGZHOU, GUANGDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: HUANG RUOPAN TO: HUANG RUOPAN JIANG WEIDONG |
|
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20111115 Address after: 510663 Guangdong Science City Guangzhou skim Springs Road No. 3, Guangzhou international business incubator D Applicant after: RayBiotech,Inc. Guangzhou Address before: Norcross, Georgia, United States Applicant before: Huang Ruopan Co-applicant before: RayBiotech,Inc. Guangzhou |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.79, Ruihe Road, Science City, Guangzhou hi tech Industrial Development Zone, Guangdong 510000 Patentee after: Reboo (Guangzhou) Biotechnology Co.,Ltd. Address before: 510663 Zone D, Guangzhou International Business Incubator, No.3, Juquan Road, Guangzhou Science City, Guangdong Province Patentee before: RAYBIOTECH, Inc. |